Literature DB >> 26891119

Progressive Generalized Lipodystrophy as a Manifestation of Autoimmune Polyglandular Syndrome Type 1.

Ekaterina Sorkina1, Elena Frolova1, Dina Rusinova1, Svetlana Polyakova1, Elena Roslavtseva1, Evgeny Vasilyev1, Vasily Petrov1, Anatoly Tiulpakov1.   

Abstract

We describe APS1 in a boy with generalized lipodystrophy, oral candidiasis, autoimmune hepatitis and adrenal insufficiency. It is the first time when generalized lipodystrophy is associated with APS1.

Entities:  

Mesh：

Year:  2016        PMID： 26891119     DOI： 10.1210/jc.2015-3722

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

2.  Autoimmune hepatitis and acquired partial lipodystrophy.

Authors:  Christopher Bakewell; Kavinda Dayasiri; Rachel M Brown; Astor Rodrigues; Rachel Williams; Geetha Anand; Girish L Gupte
Journal:  Frontline Gastroenterol       Date:  2021-05-14

Review 3.  Molecular and Cellular Bases of Lipodystrophy Syndromes.

Authors:  Jamila Zammouri; Camille Vatier; Emilie Capel; Martine Auclair; Caroline Storey-London; Elise Bismuth; Héléna Mosbah; Bruno Donadille; Sonja Janmaat; Bruno Fève; Isabelle Jéru; Corinne Vigouroux
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.